CLINICAL_TRIALS
trial_result
· 2022-07-20
Clinical Trial Update: Use of GM-CSF Treatment in Recurrent Implantation Failure [Phase 3]
Summary
A Phase 3 clinical trial evaluating GM-CSF treatment for recurrent implantation failure in IVF is in an unknown status.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Centre for Endocrinology and Reproductive Medicine, Italy | Conditions: Women With Recurrent Implantation Failure in IVF | Phase 3 | Status: UNKNOWN